STO · BICO.ST
BICO Group AB (publ)
SEK 24.15-SEK 0.10 (-0.41%)
BICO Group AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 5.0% below the high.
Loading market information…
STO · SEDANA.ST · SEK
Stock price, earnings
Quote as of Oct 29, 2026, 04:29 PM UTC. Cached market data; not a live quote.
One-year closing-price history · SEK. Historical prices are not a forecast.
Sedana Medical AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 33.76% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Sedana Medical AB (publ)’s next earnings report is currently expected on Feb 11, 2027, with estimated earnings per share of -SEK 0.03. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Sedana Medical AB (publ)’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Sedana Medical AB (publ) is a medical technology firm that engineers, promotes, and distributes healthcare devices both within Sweden and across global markets. Its product portfolio includes the Sedaconda ACD-L and Sedaconda ACD, single-use medical tools designed for delivering volatile anesthetics, alongside the Sedaconda Syringe (a 50/60ml syringe) and a Sedaconda ACD starter kit. The company also provides FlurAbsorb and FlurAbsorb-S, active carbon filtration systems engineered to collect residual anesthetic gases discharged by ventilators. Complementing these are the FlurAbsorb accessory kit, which facilitates connecting ventilator exhausts and gas monitors to the filters, and the FlurAbsorb mount, used to secure the filter during anesthetic gas removal. Further offerings encompass the AMG-06 Gas Monitor, which enables ongoing, non-invasive sidestream measurement of carbon dioxide and anesthetic levels in inhaled and exhaled breaths. Additionally, they supply the Sedaconda Filling Adapter, a disposable tool for securely and simply transferring isoflurane from its container to a Sedaconda Syringe, as well as an array of supplemental items like DRYLINE II Water Traps, the WaterLock 2 water trap, Nafion Dryer Tubing, and Respiratory Gas Monitoring Lines. Established in 1999, Sedana Medical AB (publ) maintains its corporate headquarters in Danderyd, Sweden.
Latest available per-share figures in SEK. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q2 2025 | Jul 18, 2025 | -SEK 0.13+21.28% vs estimate | SEK 49.75M+3.65% vs estimate |
|---|
| Q1 2025 | May 6, 2025 | -SEK 0.24-300.0% vs estimate | SEK 57.50M+6.47% vs estimate |
|---|
| Q4 2024 | Feb 13, 2025 | SEK 0.09+200.0% vs estimate | SEK 49.16M-1.88% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SEK 24.15-SEK 0.10 (-0.41%)
BICO Group AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 5.0% below the high.
SEK 68.40+SEK 1.20 (+1.79%)
Paxman AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 0.58% below the high.
SEK 21.80-SEK 0.20 (-0.91%)
Genovis AB’s quoted price sits in the upper half of its reported 52-week range, 7.82% below the high.
SEK 16.76-SEK 0.72 (-4.12%)
SynAct Pharma AB’s quoted price sits in the upper half of its reported 52-week range, 31.87% below the high.
SEK 23.20+SEK 1.70 (+7.91%)
C-Rad AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 41.12% below the high.
SEK 1.71+SEK 0.05 (+3.07%)
Oncopeptides AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 72.13% below the high.
SEK 3.20+SEK 0.40 (+14.08%)
Senzime AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 48.72% below the high.
SEK 3.38-SEK 0.12 (-3.3%)
OssDsign AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 74.81% below the high.
